Genome sequencing offers more Complete description of cells and organismsallowing scientists to discover serious problems genetic condition like high risk of breast cancer Also pulmonary artery hypertensionGenomics research has the potential to save lives and maintain people’s quality of life, but it is a very challenging undertaking.
In January pack bio, developer of genome sequencing instruments, further advancing genomic technology. Today PacBio introduces his Revio Sequencing System, an instrument that works with his DeepConsensus, our deep learning technology. His DeepConsensus built into Revio allows researchers to quickly and accurately identify disease-causing genetic variants.
How Google Health technology works
Genome sequencing requires viewing individual DNA molecules in a complex and noisy background. To address this issue, Google Health turned to Transformer. deep learning method Developed in 2017 primarily for language understanding. It was then applied to the data from PacBio, which uses fluorescent light to encode DNA sequences.Result is deep consensus.
Last year we demonstrated that DeepConsensus has the following capabilities: 42% reduction in sequencing errors, resulting in better genome assembly and more accurate identification of genetic variants. While this was a promising research demonstration, we knew DeepConsensus could have the greatest impact when run directly on PacBio’s sequencing machines. Last year, we worked closely with PacBio to make DeepConsensus over 500x faster than him from the first release. It also improved accuracy even further, reducing errors by 59%.
By combining our AI methodologies and genomics with PacBio’s instrumentation and expertise, we were able to build a better method for the research community. Our partnership with PacBio doesn’t stop with Revio. The possibilities are endless to influence the research community and improve healthcare and access for people around the world.
